Effect of agmatine on DAMGO-induced mu-opioid receptor down-regulation and internalization via activation of IRAS, a candidate for imidazoline I₁ receptorYAN GAO; FEI LI; NING WU et al.European journal of pharmacology. 2008, Vol 599, Num 1-3, pp 18-23, issn 0014-2999, 6 p.Article

Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomitingSUGINO, Shigekazu; HAYASE, Tomo; HIGUCHI, Misako et al.Experimental brain research. 2014, Vol 232, Num 8, pp 2627-2635, issn 0014-4819, 9 p.Conference Paper

OPIOID-INDUCED DEPRESSION IN THE LAMPREY RESPIRATORY NETWORKMUTOLO, D; BONGIANNI, F; EINUM, J et al.Neuroscience. 2007, Vol 150, Num 3, pp 720-729, issn 0306-4522, 10 p.Article

Opioid agonist and antagonist treatment differentially regulates immunoreactive μ-opioid receptors and dynamin-2 in vivoYOBURN, Byron C; PUROHIT, Vishal; PATEL, Kaushal et al.European journal of pharmacology. 2004, Vol 498, Num 1-3, pp 87-96, issn 0014-2999, 10 p.Article

Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginineWANG, Chang-Lin; CHAO GUO; WANG, Yi-Qing et al.Peptides (New York, NY. 1980). 2011, Vol 32, Num 2, pp 293-299, issn 0196-9781, 7 p.Article

Heterodimerization and cross-desensitization between the μ-opioid receptor and the chemokine CCR5 receptorCHONGGUANG CHEN; JIN LI; BOT, George et al.European journal of pharmacology. 2004, Vol 483, Num 2-3, pp 175-186, issn 0014-2999, 12 p.Article

The antitussive effects of endomorphin-1 and endomorphin-2 in miceKAMEI, Junzo; MORITA, Kayo; SAITOH, Akiyoshi et al.European journal of pharmacology. 2003, Vol 467, Num 1-3, pp 219-222, issn 0014-2999, 4 p.Article

Increased dopamine D2 receptor binding and enhanced apomorphine-induced locomotor activity in μ-opioid receptor knockout miceTIEN, Lu-Tai; PARK, Younjoo; FAN, Lir-Wan et al.Brain research bulletin. 2003, Vol 61, Num 1, pp 109-115, issn 0361-9230, 7 p.Article

Antinociception by a peripherally administered novel endomorphin-1 analogue containing β-prolineSPAMPINATO, Santi; QASEM, Ahmed R; CALIENNI, Mafia et al.European journal of pharmacology. 2003, Vol 469, Num 1-3, pp 89-95, issn 0014-2999, 7 p.Article

The presynaptic modulation of corticostriatal afferents by μ-opioids is mediated by K⁺ conductancesBARRAL, Jaime; MENDOZA, Ernesto; GALARRAGA, Elvira et al.European journal of pharmacology. 2003, Vol 462, Num 1-3, pp 91-98, issn 0014-2999, 8 p.Article

Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated miceBAILEY, Alexis; HAWKINS, Rachel M; HOURANI, Susanna M. O et al.British journal of pharmacology. 2003, Vol 139, Num 6, pp 1187-1195, issn 0007-1188, 9 p.Article

Stimulatory effect of stevioside on peripheral mu opioid receptors in animalsYANG, Po-Sheng; LEE, Jie-Jen; TSAO, Chiung-Wen et al.Neuroscience letters. 2009, Vol 454, Num 1, pp 72-75, issn 0304-3940, 4 p.Article

Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphineMIZOGUCHI, Hirokazu; BAGETTA, Giacinto; SAKURADA, Tsukasa et al.Peptides (New York, NY. 1980). 2011, Vol 32, Num 2, pp 421-427, issn 0196-9781, 7 p.Article

The Metabolism of Opioid Agents and the Clinical Impact of Their Active MetabolitesSMITH, Howard S.The Clinical journal of pain. 2011, Vol 27, Num 9, pp 824-838, issn 0749-8047, 15 p.Article

The influence of μ-opioid receptor agonist and antagonist peptides on peripheral blood mononuclear cells (PBMCs)FIEDOROWICZ, E; JARMOLOWSKA, B; IWAN, M et al.Peptides (New York, NY. 1980). 2011, Vol 32, Num 4, pp 707-712, issn 0196-9781, 6 p.Article

Mediation of protein kinase C zeta in μ-opioid receptor activation for increase of glucose uptake into cultured myoblast C₂C₁₂ cellsYANG, Ting-Ting; LIU, I-Min; WU, Hung-Tsung et al.Neuroscience letters. 2009, Vol 465, Num 2, pp 177-180, issn 0304-3940, 4 p.Article

Differences in δ-and μ-Opioid Receptor Blockade Measured by Positron Emission Tomography in Naltrexone-Treated Recently Abstinent Alcohol-Dependent SubjectsWEERTS, Elise M; YU KYEONG KIM; WAND, Gary S et al.Neuropsychopharmacology (New York, NY). 2008, Vol 33, Num 3, pp 653-665, issn 0893-133X, 13 p.Article

Effects of systemic administration of β-casomorphin-5 on learning and memory in miceSAKAGUCHI, Minoru; KOSEKI, Makoto; WAKAMATSU, Masanori et al.European journal of pharmacology. 2006, Vol 530, Num 1-2, pp 81-87, issn 0014-2999, 7 p.Article

Characterization of the [¹²⁵I]endomorphin-2 binding sites in the MCF7 breast cancer cell lineFICHNA, Jakub; KRAJEWSKA, Urszula; ROZALSKI, Marek et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 2, pp 295-299, issn 0196-9781, 5 p.Article

Enkephalinergic inhibition of raphe pallidus inputs to rat hypoglossal motoneurones in vitroBOURYI, V. A; LEWIS, D. I.Neuroscience. 2004, Vol 129, Num 1, pp 55-64, issn 0306-4522, 10 p.Article

μ opioid receptor signaling in morphine sensitizationVIGANO, D; RUBINO, T; DI CHIARA, G et al.Neuroscience. 2003, Vol 117, Num 4, pp 921-929, issn 0306-4522, 9 p.Article

Antinociceptive role of oxytocin in the nucleus raphe magnus of rats, an involvement of μ-opioid receptorWANG, Jing-Wen; LUNDEBERG, Thomas; YU, Long-Chuan et al.Regulatory peptides. 2003, Vol 115, Num 3, pp 153-159, issn 0167-0115, 7 p.Article

The μ Opioid Receptor and Ligands Acting at the μ Opioid Receptor, as Therapeutics and Potential Therapeutics : Current Perspectives and Challenges in Design, Chemistry and Pharmacology of OpioidsSPETEA, Mariana; MUHAMMAD FAHEEM ASIM; WOLBER, Gerhard et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 42, pp 7415-7434, issn 1381-6128, 20 p.Article

Prolonged central μ-opioid receptor occupancy after single and repeated nalmefene dosingINGMAN, Kimmo; HAGELBERG, Nora; AALTO, Sargo et al.Neuropsychopharmacology (New York, NY). 2005, Vol 30, Num 12, pp 2245-2253, issn 0893-133X, 9 p.Article

Sexual receptivity is reduced in the female mu-opioid receptor knockout mouseSINCHAK, Kevin; SHAHEDI, Kamyar; DEWING, Phoebe et al.Neuroreport (Oxford). 2005, Vol 16, Num 15, pp 1697-1700, issn 0959-4965, 4 p.Article